Silo Pharma Inc (SILO)

$0.45 0.00 (-0.90%)
Market Cap 6.07M
Revenue (ttm) 70,000.00
Net Income (ttm) -4.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6,271.43%
Debt to Equity Ratio 0.00
Volume 64,500
Avg Vol 526,496
Day's Range N/A - N/A
Shares Out 13.32M
Stochastic %K 78%
Beta 0.36
Analysts Strong Sell
Price Target $10.00

Company Profile

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders....

Industry: Biotechnology
Sector: Healthcare
Phone: 718 400 9031
Address:
677 North Washington Boulevard, Sarasota, United States
TaySwift
TaySwift Dec. 3 at 8:13 PM
$SILO So: 🔹 No IND has been submitted yet. 🔹 IND-enabling data is still being generated. 🔹 The company itself is telling us: “we expect to submit in 2026” On Oct 24, 2025, shareholders approved giving the board power to do a reverse split between 1-for-2 and 1-for-20 any time before Oct 24, 2026, to help keep Nasdaq listing. $2.5M registered direct offering at $0.875 with attached warrants in Oct 2025. New 424B3 prospectus filed Nov 26, 2025 registering ~3.07M shares for resale by selling securityholders.
2 · Reply
MGeronimo
MGeronimo Dec. 3 at 5:40 PM
$SILO AIF IT BREAKS .85 she will run up
1 · Reply
MGeronimo
MGeronimo Dec. 3 at 5:39 PM
$SILO going to run up
0 · Reply
Money_Too_Long
Money_Too_Long Nov. 28 at 9:21 PM
$SILO Something is brewing.
1 · Reply
SlamminSammmy
SlamminSammmy Nov. 27 at 4:19 PM
$SILO if crypto rallies in December this gonna keep climbing without news and when the news hits. Over 1 easy. Gobble gobble
0 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 26 at 9:36 PM
🎯 Target Hit 🏁 📨 From Nov 24, 2025 💊 $SILO 💵 Entry: $0.3903 ✅ Ext: $0.4507 💰 P/L: +15.48% 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
Money_Too_Long
Money_Too_Long Nov. 26 at 2:22 PM
$SILO Seem like this is trying to take off.
1 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 25 at 1:50 PM
🎯 Target Hit 🏁 📨 From Nov 21, 2025 💊 $SILO 💵 Entry: $0.3800 ✅ Ext: $0.4388 💰 P/L: +15.47% 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 24 at 10:02 AM
🚀 New Signal ✅ 💊 $SILO 🗓️ Nov 24, 2025 💵 Entry: $0.3903 🎯 Target (Opt.): $0.4507 (+15.48%) 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
Jbjb90
Jbjb90 Nov. 21 at 8:41 PM
$PBM my original position i was in at 4-5, when it pumped to 12 i held all the way through for some reason and have held since. I added at 1.52 earlier and added again just now at 1.48, this has to be the bottom 😡 pump this shit, low float and the news yesterday was good. Added this, $SILO and $ENSC off the lows. One of these is due for a jump. 💪
1 · Reply
Latest News on SILO
Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD

Nov 17, 2025, 8:05 AM EST - 18 days ago

Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD

Silo Pharma Selects Alphaledger's T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain

Oct 29, 2025, 8:25 AM EDT - 5 weeks ago

Silo Pharma Selects Alphaledger's T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain

Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program

Oct 23, 2025, 8:45 AM EDT - 6 weeks ago

Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program

Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company's Commitment to Multi-Chain Growth

Oct 8, 2025, 8:45 AM EDT - 2 months ago

Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company's Commitment to Multi-Chain Growth

Silo Pharma Acquires ResearchCoin (RSC) Crypto Tokens in Support of Decentralized Science (DeSci)

Oct 6, 2025, 8:10 AM EDT - 2 months ago

Silo Pharma Acquires ResearchCoin (RSC) Crypto Tokens in Support of Decentralized Science (DeSci)

Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Oct 1, 2025, 4:20 PM EDT - 2 months ago

Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Sep 30, 2025, 8:02 AM EDT - 2 months ago

Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Silo Pharma Announces Initial Investment in Ethereum and Solana under Cryptocurrency Treasury Strategy

Sep 16, 2025, 8:11 AM EDT - 2 months ago

Silo Pharma Announces Initial Investment in Ethereum and Solana under Cryptocurrency Treasury Strategy

Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug

Sep 9, 2025, 9:10 AM EDT - 3 months ago

Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug

Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio

Sep 3, 2025, 8:25 AM EDT - 3 months ago

Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio

Silo Pharma's Alzheimer's Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal

Aug 21, 2025, 2:00 PM EDT - 3 months ago

Silo Pharma's Alzheimer's Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal

Silo Pharma's PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway

Aug 19, 2025, 8:05 AM EDT - 3 months ago

Silo Pharma's PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway

Silo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury Platform

Aug 5, 2025, 8:32 AM EDT - 4 months ago

Silo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury Platform

Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15

Jul 16, 2025, 8:45 AM EDT - 5 months ago

Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15

Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025

Jul 7, 2025, 8:15 AM EDT - 5 months ago

Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025

Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

Jun 25, 2025, 8:38 AM EDT - 5 months ago

Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.

Jun 25, 2025, 8:27 AM EDT - 5 months ago

Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.

HOTH

Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears

Jun 11, 2025, 9:00 AM EDT - 6 months ago

Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears

Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

Jun 5, 2025, 9:15 AM EDT - 6 months ago

Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

May 21, 2025, 8:55 AM EDT - 7 months ago

Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

Silo Pharma Announces Closing of $2 Million Public Offering

May 16, 2025, 4:15 PM EDT - 7 months ago

Silo Pharma Announces Closing of $2 Million Public Offering

Silo Pharma Announces Pricing of $2 Million Public Offering

May 15, 2025, 9:15 AM EDT - 7 months ago

Silo Pharma Announces Pricing of $2 Million Public Offering

Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15

May 14, 2025, 4:07 PM EDT - 7 months ago

Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15

Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories

May 14, 2025, 8:40 AM EDT - 7 months ago

Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories

Silo Pharma's SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

Apr 30, 2025, 8:11 AM EDT - 7 months ago

Silo Pharma's SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer's Drug

Apr 28, 2025, 7:50 AM EDT - 7 months ago

Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer's Drug

Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment

Mar 26, 2025, 8:40 AM EDT - 9 months ago

Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment

Silo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment

Feb 26, 2025, 1:30 PM EST - 10 months ago

Silo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment

Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment

Feb 18, 2025, 8:50 AM EST - 10 months ago

Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment

Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and Fibromyalgia

Feb 11, 2025, 7:45 AM EST - 10 months ago

Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and Fibromyalgia

Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD Treatment

Jan 22, 2025, 8:29 AM EST - 11 months ago

Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD Treatment

Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain

Jan 2, 2025, 8:45 AM EST - 1 year ago

Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain

Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and Fibromyalgia

Dec 18, 2024, 7:35 AM EST - 1 year ago

Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and Fibromyalgia

Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management

Nov 29, 2024, 8:05 AM EST - 1 year ago

Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management

Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders

Nov 18, 2024, 8:40 AM EST - 1 year ago

Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders

Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant

Oct 31, 2024, 8:35 AM EDT - 1 year ago

Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant

Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD

Sep 10, 2024, 6:35 AM EDT - 1 year ago

Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD

Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic

Aug 14, 2024, 2:30 PM EDT - 1 year ago

Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic

Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide

Aug 7, 2024, 8:13 AM EDT - 1 year ago

Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide

Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference

Jul 26, 2024, 8:20 AM EDT - 1 year ago

Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference

Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jul 22, 2024, 4:45 PM EDT - 1 year ago

Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jul 19, 2024, 8:01 AM EDT - 1 year ago

Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Silo Pharma Finds Partner For Device Development for Intranasal PTSD Drug

Jul 18, 2024, 12:44 PM EDT - 1 year ago

Silo Pharma Finds Partner For Device Development for Intranasal PTSD Drug

Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15

Jul 18, 2024, 8:25 AM EDT - 1 year ago

Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15

Why Is Nano-Cap Silo Pharma Stock Skyrocketing On Tuesday?

Jul 16, 2024, 10:50 AM EDT - 1 year ago

Why Is Nano-Cap Silo Pharma Stock Skyrocketing On Tuesday?

Silo Pharma Secures Exclusive Global License for Alzheimer's Therapeutic

Jul 16, 2024, 6:30 AM EDT - 1 year ago

Silo Pharma Secures Exclusive Global License for Alzheimer's Therapeutic

Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety

Jun 26, 2024, 8:50 AM EDT - 1 year ago

Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety

Silo Pharma Announces Successful Production of its SP-26 Ketamine Implant for Fibromyalgia

Jun 7, 2024, 8:18 AM EDT - 1 year ago

Silo Pharma Announces Successful Production of its SP-26 Ketamine Implant for Fibromyalgia

Silo Pharma Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jun 6, 2024, 4:50 PM EDT - 1 year ago

Silo Pharma Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Silo Pharma Submits Pre-Investigational New Drug Application to FDA for SPC-15 as a Treatment for PTSD and Anxiety

Jun 4, 2024, 8:41 AM EDT - 1 year ago

Silo Pharma Submits Pre-Investigational New Drug Application to FDA for SPC-15 as a Treatment for PTSD and Anxiety

TaySwift
TaySwift Dec. 3 at 8:13 PM
$SILO So: 🔹 No IND has been submitted yet. 🔹 IND-enabling data is still being generated. 🔹 The company itself is telling us: “we expect to submit in 2026” On Oct 24, 2025, shareholders approved giving the board power to do a reverse split between 1-for-2 and 1-for-20 any time before Oct 24, 2026, to help keep Nasdaq listing. $2.5M registered direct offering at $0.875 with attached warrants in Oct 2025. New 424B3 prospectus filed Nov 26, 2025 registering ~3.07M shares for resale by selling securityholders.
2 · Reply
MGeronimo
MGeronimo Dec. 3 at 5:40 PM
$SILO AIF IT BREAKS .85 she will run up
1 · Reply
MGeronimo
MGeronimo Dec. 3 at 5:39 PM
$SILO going to run up
0 · Reply
Money_Too_Long
Money_Too_Long Nov. 28 at 9:21 PM
$SILO Something is brewing.
1 · Reply
SlamminSammmy
SlamminSammmy Nov. 27 at 4:19 PM
$SILO if crypto rallies in December this gonna keep climbing without news and when the news hits. Over 1 easy. Gobble gobble
0 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 26 at 9:36 PM
🎯 Target Hit 🏁 📨 From Nov 24, 2025 💊 $SILO 💵 Entry: $0.3903 ✅ Ext: $0.4507 💰 P/L: +15.48% 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
Money_Too_Long
Money_Too_Long Nov. 26 at 2:22 PM
$SILO Seem like this is trying to take off.
1 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 25 at 1:50 PM
🎯 Target Hit 🏁 📨 From Nov 21, 2025 💊 $SILO 💵 Entry: $0.3800 ✅ Ext: $0.4388 💰 P/L: +15.47% 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 24 at 10:02 AM
🚀 New Signal ✅ 💊 $SILO 🗓️ Nov 24, 2025 💵 Entry: $0.3903 🎯 Target (Opt.): $0.4507 (+15.48%) 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
Jbjb90
Jbjb90 Nov. 21 at 8:41 PM
$PBM my original position i was in at 4-5, when it pumped to 12 i held all the way through for some reason and have held since. I added at 1.52 earlier and added again just now at 1.48, this has to be the bottom 😡 pump this shit, low float and the news yesterday was good. Added this, $SILO and $ENSC off the lows. One of these is due for a jump. 💪
1 · Reply
Jbjb90
Jbjb90 Nov. 21 at 8:15 PM
$SILO we have to be close to a bottom here, once news drops onwards and upwards 💪
1 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Nov. 20 at 11:05 PM
$SILO CEO purchased 12,000 shares at $0.40 for a total of $4,847. Weisblum Eric now owns 209,932 shares. https://ceo-buys.com
0 · Reply
TaySwift
TaySwift Nov. 19 at 7:49 PM
$SILO do you think they'll do a reverse split here?
1 · Reply
TaySwift
TaySwift Nov. 18 at 5:57 PM
$SILO do they have to meet compliance by December?
1 · Reply
isaacwilliams33
isaacwilliams33 Nov. 17 at 5:33 PM
$SILO radar
0 · Reply
DARKP00L
DARKP00L Nov. 17 at 1:31 PM
$SILO 08:10 on Nov. 17 2025 Silo Pharma Selects Allucent To Support Preparations And Planned Submission Of IND For Phase 1 Trial Of SPC-15 As A Therapeutic For PTSD #tradeideas
0 · Reply
Jbjb90
Jbjb90 Nov. 17 at 1:13 PM
$SILO https://www.stocktitan.net/news/SILO/silo-pharma-partners-with-allucent-to-support-planned-fda-9gzbkjaefcyh.html
1 · Reply
Lyn30
Lyn30 Nov. 14 at 7:50 PM
$SILO It’s amazing how easily they bring a stock so down. Possible scenario : They keep selling at lower prices that they don’t even own. Then holders lose the grip from fear and start selling . Then paid worker start all over posting RS, scam etc. so no one feel like to buy. So buyers not there and selling pressure continues how come stock can go up 😂. So basically shorts wins most of the time imo
1 · Reply
Lyn30
Lyn30 Nov. 11 at 8:59 AM
$SILO as per Market beat 3 Under-the-Radar Biotechs Under $5 That Could Soar 200% Silo is one of the mentioned stock with precise reasoning .
0 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 10 at 3:11 PM
🚀 New Signal ✅ 💊 $SILO 🗓️ Nov 10, 2025 💵 Entry: $0.4743 🎯 Target (Opt.): $0.5638 (+18.87%) 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
SlamminSammmy
SlamminSammmy Nov. 9 at 3:48 AM
$SILO gonna blast off before EOY. 1.5+ at least, been loading the boat at these levels
0 · Reply
Lyn30
Lyn30 Nov. 8 at 5:41 PM
$SILO Watching this one for entry History of 260% surge as well as many big run. Next pump may come from crypto into treasury management strategy. Last offering was .875 Resistance @ 1.
0 · Reply